New Consortium Members

As of 24th June 2019, Roche Austria GmbH and Roche Diagnostic GmbH have joined the CBmed consortium. Within the second COMET funding period, the new partners will be involved in 2 projects in the field of cancer treatment. Just recently, Roche has launched its NAVIFY Tumor Board solution, enforcing data driven applications within the clinical setting. Together with Roche, CBmed will have the opportunity to build on previous successes of the first funding period, including advancing of natural language processing together with clinical phenotyping and its inhouse FUSION technology with a strong focus on cross-platform data integration.